Fjarde Ap-fonden’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Buy
293,866
+1,087
+0.4% +$87.7K 0.11% 174
2026
Q1
$25.4M Buy
292,779
+107,000
+58% +$10.3M 0.14% 138
2025
Q4
$17.8M Sell
185,779
-4,600
-2% -$447K 0.15% 130
2025
Q3
$18.1M Buy
190,379
+1,600
+0.8% +$147K 0.16% 137
2025
Q2
$16.5M Buy
188,779
+27,700
+17% +$2.35M 0.15% 143
2025
Q1
$14.5M Sell
161,079
-131,800
-45% -$11.8M 0.17% 127
2024
Q4
$23.4M Sell
292,879
-48,200
-14% -$4.17M 0.24% 80
2024
Q3
$30.7M Buy
+341,079
New +$28.7M 0.31% 62
2024
Q1
$30.9M Buy
354,379
+4,900
+1% +$418K 0.34% 53
2023
Q4
$28.8M Sell
349,479
-31,792
-8% -$2.42M 0.36% 49
2023
Q3
$29.9M Sell
381,271
-6,600
-2% -$553K 0.4% 43
2023
Q2
$34.2M Sell
387,871
-29,800
-7% -$2.57M 0.42% 43
2023
Q1
$33.7M Sell
417,671
-7,800
-2% -$636K 0.45% 42
2022
Q4
$33.1M Buy
425,471
+27,000
+7% +$2.19M 0.47% 42
2022
Q3
$35.8M Hold
398,471
0.45% 42
2022
Q2
$35.8M Buy
398,471
+48,000
+14% +$4.86M 0.45% 42
2022
Q1
$38.9M Sell
350,471
-44,291
-11% -$4.68M 0.38% 46
2021
Q4
$40.8M Sell
394,762
-6,900
-2% -$799K 0.36% 53
2021
Q3
$50.3M Sell
401,662
-14,700
-4% -$1.9M 0.46% 47
2021
Q2
$51.7M Sell
416,362
-10,100
-2% -$1.27M 0.47% 44
2021
Q1
$50.4M Buy
426,462
+16,700
+4% +$1.96M 0.46% 41
2020
Q4
$48M Buy
409,762
+4,200
+1% +$462K 0.46% 43
2020
Q3
$42.1M Buy
405,562
+13,700
+3% +$1.38M 0.46% 43
2020
Q2
$35.9M Buy
391,862
+16,000
+4% +$1.53M 0.45% 46
2020
Q1
$33.9M Sell
375,862
-19,800
-5% -$2.11M 0.55% 36
2019
Q4
$44.9M Buy
395,662
+5,600
+1% +$615K 0.55% 32
2019
Q3
$42.4M Sell
390,062
-16,691
-4% -$1.74M 0.55% 33
2019
Q2
$39.6M Sell
406,753
-13,600
-3% -$1.24M 0.51% 37
2019
Q1
$38.3M Buy
420,353
+102,362
+32% +$9.16M 0.48% 39
2018
Q4
$28.9M Sell
317,991
-44,100
-12% -$4.12M 0.5% 37
2018
Q3
$35.6M Sell
362,091
-16,700
-4% -$1.54M 0.52% 38
2018
Q2
$32.4M Sell
378,791
-2,557
-0.7% -$214K 0.49% 42
2018
Q1
$30.6M Buy
381,348
+1,949
+0.5% +$161K 0.47% 42
2017
Q4
$30.6M Buy
379,399
+57,020
+18% +$4.57M 0.46% 41
2017
Q3
$25.1M Buy
322,379
+1,389
+0.4% +$115K 0.48% 41
2017
Q2
$28.5M Buy
320,990
+38,705
+14% +$3.26M 0.57% 34
2017
Q1
$22.7M Sell
282,285
-19,671
-7% -$1.54M 0.54% 34
2016
Q4
$21.5M Sell
301,956
-29,571
-9% -$2.32M 0.5% 37
2016
Q3
$28.6M Buy
331,527
+7,318
+2% +$638K 0.63% 33
2016
Q2
$28.1M Buy
324,209
+1,120
+0.3% +$90.6K 0.65% 32
2016
Q1
$24.2M Buy
323,089
+42,131
+15% +$3.17M 0.56% 39
2015
Q4
$21.7M Buy
280,958
+368
+0.1% +$27.7K 0.57% 38
2015
Q3
$18.9M Sell
280,590
-17,183
-6% -$1.27M 0.53% 39
2015
Q2
$22.2M Sell
297,773
-18,554
-6% -$1.42M 0.54% 39
2015
Q1
$24.8M Buy
316,327
+81,449
+35% +$6.17M 0.57% 36
2014
Q4
$17M Buy
234,878
+10,496
+5% +$729K 0.37% 59
2014
Q3
$13.9M Sell
224,382
-48,667
-18% -$3.09M 0.3% 74
2014
Q2
$17.4M Sell
273,049
-13,582
-5% -$825K 0.35% 63
2014
Q1
$17.6M Buy
286,631
+8,511
+3% +$496K 0.35% 61
2013
Q4
$16M Sell
278,120
-22,752
-8% -$1.29M 0.33% 66
2013
Q3
$16M Sell
300,872
-18,581
-6% -$1,000K 0.35% 63
2013
Q2
$16.4M Buy
+319,453
New +$15.8M 0.34% 61

Other funds holding MDT

Fjarde Ap-fonden's MDT Position: Q2 2026 in Review

Fjarde Ap-fonden increased its Medtronic (MDT) stake by 0.37% in Q2 2026, buying an estimated $87.7K and bringing the position to 293,866 shares worth $23M. The position accounts for 0.11% of the portfolio, ranked #174.

Fjarde Ap-fonden first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $51.7M in Q2 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fjarde Ap-fonden held 293,866 shares of Medtronic worth $23M as of Q2 2026.
  • Fjarde Ap-fonden bought 1,087 Medtronic shares in Q2 2026, an estimated $87.7K.
  • Medtronic made up 0.11% of Fjarde Ap-fonden's portfolio in Q2 2026, its #174 holding.
  • Fjarde Ap-fonden first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Fjarde Ap-fonden's Medtronic position peaked at $51.7M in Q2 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.